Illumina, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4523271090
USD
164.93
3.55 (2.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Gilead Sciences, Inc.
Biogen, Inc.
Halozyme Therapeutics, Inc.
Amgen, Inc.
Bio-Techne Corp.
Elanco Animal Health, Inc.
Illumina, Inc.
BioMarin Pharmaceutical, Inc.
Moderna, Inc.
Vaxcyte, Inc.
Immunovant, Inc.

Why is Illumina, Inc. ?

1
The company is Net-Debt Free
2
Poor long term growth as Operating profit has grown by an annual rate 9.08% of over the last 5 years
3
Positive results in Mar 26
  • OPERATING CASH FLOW(Y) Highest at USD 1,128 MM
  • ROCE(HY) Highest at 33.82%
  • RAW MATERIAL COST(Y) Fallen by -0.45% (YoY)
4
With ROCE of 28.32%, it has a expensive valuation with a 7.29 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 82.02%, its profits have risen by 50.2% ; the PEG ratio of the company is 0.6
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Market Beating Performance
  • The stock has generated a return of 82.02% in the last 1 year, much higher than market (S&P 500) returns of 22.24%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Illumina, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Illumina, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Illumina, Inc.
82.02%
1.14
47.97%
S&P 500
22.24%
1.67
13.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
6.03%
EBIT Growth (5y)
9.08%
EBIT to Interest (avg)
5.03
Debt to EBITDA (avg)
1.05
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.89
Tax Ratio
8.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
14.04%
ROE (avg)
8.97%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
8.29
EV to EBIT
25.74
EV to EBITDA
19.76
EV to Capital Employed
7.29
EV to Sales
5.30
PEG Ratio
0.63
Dividend Yield
NA
ROCE (Latest)
28.32%
ROE (Latest)
23.44%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 1,128 MM

ROCE(HY)

Highest at 33.82%

RAW MATERIAL COST(Y)

Fallen by -0.45% (YoY

-4What is not working for the Company
NET PROFIT(9M)

At USD 518.18 MM has Grown at -37.01%

OPERATING PROFIT MARGIN(Q)

Lowest at 24.11 %

Here's what is working for Illumina, Inc.

Operating Cash Flow
Highest at USD 1,128 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Raw Material Cost
Fallen by -0.45% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Illumina, Inc.

Net Profit
At USD 518.18 MM has Grown at -37.01%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit Margin
Lowest at 24.11 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales